← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2008Last known activity
Mar 31, 2026
Timeline
1990s
- Jun 1, 1997
KGK Science Inc.— Founded
Drugs by trial phase (81 distinct, 64 trials)
Phase 2 (39 own, 0 via acquisition)
Phase 1 (20 own, 0 via acquisition)
Other trials (22 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT07255079CollaboratorN/AMar 31, 2026
- NCT07034794CollaboratorN/ANov 30, 2025
- NCT07034794OfficialN/ANov 30, 2025
- NCT07149064CollaboratorN/ANov 30, 2025
- NCT07149064OfficialN/ANov 30, 2025
- NCT07004023OfficialN/AOct 31, 2025
- NCT07004023CollaboratorN/AOct 31, 2025
- NCT07043478OfficialN/AAug 5, 2025
- NCT07043478CollaboratorN/AAug 5, 2025
- NCT06967051CollaboratorN/AMay 22, 2025
- NCT06967051OfficialN/AMay 22, 2025
- NCT06256575CollaboratorN/ADec 15, 2024
- NCT06573814OfficialPhase 2Oct 25, 2024
- NCT05808595Overall official - principal investigatorPhase 2Apr 11, 2023
- NCT05808595CollaboratorPhase 2Apr 11, 2023
Details
- Founded
- London, US Jun 1, 1997
- Last known activity
- Mar 31, 2026
Notes
CRO